Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Joseph Ortiz MD
Joseph M. Ortiz MD Advisory Board
Leonard Press OD, FAAO, FCOVD
Leonard J. Press OD, FAAO, FCOVD Associate Editor
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO Advisory Board
See All Experts
featured
Published in Eye Care

Journal Scan / Research · April 18, 2019

The Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration

Ophthalmology

 

 Save  Recommend
 Share

Additional Info

Ophthalmology
The Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration: Results From the Randomized Phase II Ladder Clinical
Ophthalmology 2019 Apr 01;[EPub Ahead of Print], PA Campochiaro, DM Marcus, CC Awh, C Regillo, AP Adamis, V Bantseev, Y Chiang, JS Ehrlich, S Erickson, WD Hanley, J Horvath, KF Maass, N Singh, F Tang, G Barteselli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated